Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gain Therapeutics, Inc.

2.34
+0.05002.18%
Post-market: 2.340.00000.00%16:46 EDT
Volume:126.19K
Turnover:298.31K
Market Cap:62.07M
PE:-2.16
High:2.43
Open:2.30
Low:2.30
Close:2.29
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
Loading ...

Gain Therapeutics Q3 2024 GAAP EPS $(0.17) Beats $(0.21) Estimate

Benzinga
·
14 Nov 2024

Gain Therapeutics Inc: Qtrly Shr Loss $0.17

THOMSON REUTERS
·
14 Nov 2024

Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

Dow Jones
·
14 Nov 2024

Gain Therapeutics Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

Gain Therapeutics presents data at 36th ENA symposium

TIPRANKS
·
23 Oct 2024

Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2

GlobeNewswire
·
23 Oct 2024

Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
15 Oct 2024

Gain Therapeutics to present at MJFF’s Annual Parkinson’s Disease Conference

TIPRANKS
·
09 Oct 2024

Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference

GlobeNewswire
·
09 Oct 2024

Gain Therapeutics Excels in Neurodegenerative Drug Trials

TIPRANKS
·
08 Oct 2024

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024

GlobeNewswire
·
07 Oct 2024

Gain Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire
·
03 Oct 2024

Buy Rating Affirmed for Gain Therapeutics on GT-02287’s Promising Parkinson’s Disease Trial Data and Solid Financials

TIPRANKS
·
01 Oct 2024

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Oct 2024

Buy Rating Affirmed for Gain Therapeutics’ GT-02287 on Promising Phase 1 Results and Potential in Parkinson’s Disease Treatment

TIPRANKS
·
01 Oct 2024

Gain Therapeutics presents Phase 1 GT-02287 data

TIPRANKS
·
30 Sep 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."